Literature DB >> 16694453

DEVELOPMENT OF ANTIFIBRINOLYTIC PROPERTIES IN BLOOD OF PATIENTS WITH RHEUMATIC FEVER, CHRONIC INFECTIVE ARTHRITIS AND BACTERIAL ENDOCARDITIS.

E Waaler1.   

Abstract

Entities:  

Year:  1937        PMID: 16694453      PMCID: PMC424854          DOI: 10.1172/JCI100832

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  STREPTOCOCCAL AGGLUTININS AND ANTISTREPTOLYSINS IN RHEUMATOID (ATROPHIC) ARTHRITIS.

Authors:  J E Blair; F A Hallman
Journal:  J Clin Invest       Date:  1935-09       Impact factor: 14.808

2.  THE OCCURRENCE OF ANTIFIBRINOLYTIC PROPERTIES IN THE BLOOD OF PATIENTS WITH ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett
Journal:  J Clin Invest       Date:  1935-03       Impact factor: 14.808

3.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

4.  THE RESISTANCE TO FIBRINOLYTIC ACTIVITY OF THE HEMOLYTIC STREPTOCOCCUS WITH SPECIAL REFERENCE TO PATIENTS WITH RHEUMATIC FEVER AND RHEUMATOID (ATROPHIC) ARTHRITIS.

Authors:  W K Myers; C S Keefer; W F Holmes
Journal:  J Clin Invest       Date:  1935-01       Impact factor: 14.808

5.  STUDIES ON THE IMMUNE RESPONSE OF THE RHEUMATIC SUBJECT AND ITS RELATIONSHIP TO ACTIVITY OF THE RHEUMATIC PROCESS. VI. THE SIGNIFICANCE OF THE RISE OF ANTISTREPTOLYSIN LEVEL IN THE DEVELOPMENT OF RHEUMATIC ACTIVITY.

Authors:  A F Coburn; R H Pauli
Journal:  J Clin Invest       Date:  1935-11       Impact factor: 14.808

  5 in total
  5 in total

1.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett
Journal:  Bacteriol Rev       Date:  1938-12

2.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

3.  THE IN VITRO AND IN VIVO EFFECT OF SULFONAMIDES UPON THE STREPTOCOCCAL ANTIFIBRINOLYSIN TEST.

Authors:  W M Kirby; L A Rantz
Journal:  J Clin Invest       Date:  1942-05       Impact factor: 14.808

4.  THE STREPTOCOCCAL ANTIFIBRINOLYSIN TEST IN CLINICAL USE.

Authors:  P L Boisvert
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

5.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. III. A QUANTITATIVE METHOD FOR THE ESTIMATION OF SERUM ANTIFIBRINOLYSIN.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.